Mind the (Vote) Gap: Can We Get More STEM Students to the Polls?
This article is part of the magazine, "The Future of Science In America: The Election Issue," co-published by LeapsMag, the Aspen Institute Science & Society Program, and GOOD.
By the numbers, American college students who major in STEM disciplines—science, technology, engineering, and math—aren't big on voting. In fact, recent research suggests they're the least likely group of students to head to the ballot box, even as American political leaders cast doubt on the very kinds of expertise those students are developing on campus.
Worried educators say it's time for a rethink of STEM education at the college level. Armed with success stories and model courses, educators are pushing for colleagues to add relevance to STEM education—and instill a sense of civic duty—by bringing the outside world in.
"It's a matter of what's in the curriculum, how faculty spend their time. There are opportunities to weave [policy] within the curriculum," said Nancy L. Thomas, director of Tufts University's Institute for Democracy & Higher Education.
The most recent student voting numbers come from the 2018 mid-term election, when a national Democratic wave brought voters to the polls. Just over a third of STEM college students surveyed said they voted, the lowest percentage of six subject areas, according to a report from the institute at Tufts. Students in the education, social sciences, and humanities fields had the highest voting rates at 47%, 41%, and 39%, respectively.
Students across the board were much less engaged in the mid-year election of 2014, when just 28% of education students surveyed said they voted. STEM students again stood at the rear, with just 16% voting.
(The report analyzed whether more than 10 million college students at 1,031 U.S. institutions voted in 2014 and 2018. At the request of this magazine, the institute at Tufts removed non-U.S. resident students—who can't vote—from the findings to see if the results changed. Voting rates among STEM students remained among the lowest.)
Why aren't STEM students engaged in politics? "I have no reason to think that science students don't care about public policy issues," Tufts University's Thomas said. Instead, she believes that colleges fail to inspire STEM students to think beyond lectures and homework.
Enter the SENCER project—Science Education for New Civic Engagements and Responsibilities. Since 2001, the project has taught thousands of educators and students how to connect science and citizenship.
The roots of the project go back to 1990, when Rutgers University microbiologist Monica Devanas was assigned to teach a general-education class called "Biomedical Issues of AIDS." She decided to expand the curriculum to encompass insights about a wide range of societal issues. Guest speakers from the community, including a man with a grim diagnosis, talked about the disease and its spread. And Devanas's colleagues in a wide variety of disciplines offered course sections about AIDS and its role in areas such as literature, prisons and law.
"I always tried to make a connection, hoping to create scientifically engaged citizens by explaining the science to them in ways that they could understand."
When she first taught the class, 450 students signed up instead of the expected 100. Devanas, who'd only ever taught a few dozen students with a blackboard, suddenly had to figure out how to teach hundreds at once with the standard technology of the time: an overhead projector.
Devanas, who taught the hugely popular class for the next 18 years, said the course worked because it linked the AIDS epidemic, a hot topic at the time, to the outer world beyond immune cells and test tubes. "You really need to make it very personal and relevant. When you talk about treatment for AIDS or the cost of drugs: Who pays for this?" she said. "I always tried to make a connection, hoping to create scientifically engaged citizens by explaining the science to them in ways that they could understand."
How can other educators learn to create compelling courses? The SENCER website offers dozens of model classes for college and K–12 educators, all with the aim of making STEM classes relevant. An engineering course, for example, could expand a discussion about the nuts and bolts of automated vehicles into a conversation about whether the cars are a good idea in the first place, said Eliza J. Reilly, executive director of the National Center for Science and Civic Engagement, where SENCER is based.
SENCER, which is government-funded, holds regular conferences and has conducted research that supports the effectiveness of its programs. "This is an educational and intellectual project rather than a get-out-the-vote project. It's not intended to create activists. Instead, it's intended to help students understand that they have power as citizens," Reilly said.
What about long-term change? Will inspiring college students to engage with politics turn them into lifetime voters? Reilly said she's not aware of any research into whether STEM students continue to vote at lower levels after they graduate. That means there's no way to know if limited civic engagement in college translates to lifelong apathy. We also don't know if lower voting rates in college may help explain why few people with STEM backgrounds run for higher office.
There's another big unknown: If more people with STEM degrees vote, will they actually support fact-based policies and candidates who listen to science? The answer is not as obvious as it may appear. At Rutgers, professor Devanas pointed to the research of Yale University law/psychology professor Dan Kahan, who found that the most scientifically literate people in the U.S. also happen to be among those most polarized over climate change. In other words, a scientific mind may not necessarily translate to a pro-science vote.
Regardless of the ultimate choices that STEM students make at the ballot box, advocates will keep encouraging educators to connect science to the world beyond the classroom. As Tufts University's Thomas explained, "it just takes a lot of creativity and will."
[Editor's Note: To read other articles in this special magazine issue, visit the beautifully designed e-reader version.]
When a patient is diagnosed with early-stage breast cancer, having surgery to remove the tumor is considered the standard of care. But what happens when a patient can’t have surgery?
Whether it’s due to high blood pressure, advanced age, heart issues, or other reasons, some breast cancer patients don’t qualify for a lumpectomy—one of the most common treatment options for early-stage breast cancer. A lumpectomy surgically removes the tumor while keeping the patient’s breast intact, while a mastectomy removes the entire breast and nearby lymph nodes.
Fortunately, a new technique called cryoablation is now available for breast cancer patients who either aren’t candidates for surgery or don’t feel comfortable undergoing a surgical procedure. With cryoablation, doctors use an ultrasound or CT scan to locate any tumors inside the patient’s breast. They then insert small, needle-like probes into the patient's breast which create an “ice ball” that surrounds the tumor and kills the cancer cells.
Cryoablation has been used for decades to treat cancers of the kidneys and liver—but only in the past few years have doctors been able to use the procedure to treat breast cancer patients. And while clinical trials have shown that cryoablation works for tumors smaller than 1.5 centimeters, a recent clinical trial at Memorial Sloan Kettering Cancer Center in New York has shown that it can work for larger tumors, too.
In this study, doctors performed cryoablation on patients whose tumors were, on average, 2.5 centimeters. The cryoablation procedure lasted for about 30 minutes, and patients were able to go home on the same day following treatment. Doctors then followed up with the patients after 16 months. In the follow-up, doctors found the recurrence rate for tumors after using cryoablation was only 10 percent.
For patients who don’t qualify for surgery, radiation and hormonal therapy is typically used to treat tumors. However, said Yolanda Brice, M.D., an interventional radiologist at Memorial Sloan Kettering Cancer Center, “when treated with only radiation and hormonal therapy, the tumors will eventually return.” Cryotherapy, Brice said, could be a more effective way to treat cancer for patients who can’t have surgery.
“The fact that we only saw a 10 percent recurrence rate in our study is incredibly promising,” she said.
Few things are more painful than a urinary tract infection (UTI). Common in men and women, these infections account for more than 8 million trips to the doctor each year and can cause an array of uncomfortable symptoms, from a burning feeling during urination to fever, vomiting, and chills. For an unlucky few, UTIs can be chronic—meaning that, despite treatment, they just keep coming back.
But new research, presented at the European Association of Urology (EAU) Congress in Paris this week, brings some hope to people who suffer from UTIs.
Clinicians from the Royal Berkshire Hospital presented the results of a long-term, nine-year clinical trial where 89 men and women who suffered from recurrent UTIs were given an oral vaccine called MV140, designed to prevent the infections. Every day for three months, the participants were given two sprays of the vaccine (flavored to taste like pineapple) and then followed over the course of nine years. Clinicians analyzed medical records and asked the study participants about symptoms to check whether any experienced UTIs or had any adverse reactions from taking the vaccine.
The results showed that across nine years, 48 of the participants (about 54%) remained completely infection-free. On average, the study participants remained infection free for 54.7 months—four and a half years.
“While we need to be pragmatic, this vaccine is a potential breakthrough in preventing UTIs and could offer a safe and effective alternative to conventional treatments,” said Gernot Bonita, Professor of Urology at the Alta Bro Medical Centre for Urology in Switzerland, who is also the EAU Chairman of Guidelines on Urological Infections.
The news comes as a relief not only for people who suffer chronic UTIs, but also to doctors who have seen an uptick in antibiotic-resistant UTIs in the past several years. Because UTIs usually require antibiotics, patients run the risk of developing a resistance to the antibiotics, making infections more difficult to treat. A preventative vaccine could mean less infections, less antibiotics, and less drug resistance overall.
“Many of our participants told us that having the vaccine restored their quality of life,” said Dr. Bob Yang, Consultant Urologist at the Royal Berkshire NHS Foundation Trust, who helped lead the research. “While we’re yet to look at the effect of this vaccine in different patient groups, this follow-up data suggests it could be a game-changer for UTI prevention if it’s offered widely, reducing the need for antibiotic treatments.”